Literature DB >> 16375713

Emerging influenza viruses: past and present.

Darwyn Kobasa1, Yoshihiro Kawaoka.   

Abstract

Influenza is an example of a disease for which the viral pathogen has emerged into the human population many times over past centuries, sometimes with devastating consequences [1]. Historical records provide vivid descriptions of past influenza outbreaks, and the viruses that caused the pandemics of the last century remain subjects of great interest. It is almost certain that a new pandemic, caused by the zoonotic transmission of a new influenza virus into humans, will occur. The recent outbreaks of the highly pathogenic H5 and H7 subtype viruses in poultry and their limited transmission into humans, as well as transmission of H9 subtype viruses, have raised concerns that conditions are developing for the generation of a new pandemic virus. In this paper, we review past pandemics, viral determinants of cross-species transmission of viruses, molecular factors that contribute to disease, and preventative measures to reduce the impact of a future pandemic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16375713     DOI: 10.2174/156652405774962281

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  11 in total

1.  The panorama of the diversity of H5 subtype influenza viruses.

Authors:  Hong-Chao Ma; Ji-Ming Chen; Ji-Wang Chen; Ying-Xue Sun; Jin-Ming Li; Zhi-Liang Wang
Journal:  Virus Genes       Date:  2006-08-19       Impact factor: 2.332

Review 2.  Cross-species virus transmission and the emergence of new epidemic diseases.

Authors:  Colin R Parrish; Edward C Holmes; David M Morens; Eun-Chung Park; Donald S Burke; Charles H Calisher; Catherine A Laughlin; Linda J Saif; Peter Daszak
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

3.  The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.

Authors:  Christopher D O'Donnell; Leatrice Vogel; Yumiko Matsuoka; Hong Jin; Kanta Subbarao
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States.

Authors:  Jessica J Hayward; Edward J Dubovi; Janet M Scarlett; Stephanie Janeczko; Edward C Holmes; Colin R Parrish
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

5.  Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.

Authors:  Katherine A Richards; Francisco A Chaves; Frederick R Krafcik; David J Topham; Christopher A Lazarski; Andrea J Sant
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

6.  Structure function studies on different structural domains of nucleoprotein of H1N1 subtype.

Authors:  Parveen Salahuddin; Asad U Khan
Journal:  Bioinformation       Date:  2010-06-24

7.  Biophysical analysis of influenza A virus RNA promoter at physiological temperatures.

Authors:  Erin Noble; David H Mathews; Jonathan L Chen; Douglas H Turner; Toru Takimoto; Baek Kim
Journal:  J Biol Chem       Date:  2011-05-09       Impact factor: 5.157

8.  Structural and functional analysis of NS1 and NS2 proteins of H1N1 subtype.

Authors:  Parveen Salahuddin; Asad U Khan
Journal:  Genomics Proteomics Bioinformatics       Date:  2010-09       Impact factor: 7.691

9.  Distinct Host Tropism Protein Signatures to Identify Possible Zoonotic Influenza A Viruses.

Authors:  Christine L P Eng; Joo Chuan Tong; Tin Wee Tan
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

10.  Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses.

Authors:  Peter R Wilker; Jorge M Dinis; Gabriel Starrett; Masaki Imai; Masato Hatta; Chase W Nelson; David H O'Connor; Austin L Hughes; Gabriele Neumann; Yoshihiro Kawaoka; Thomas C Friedrich
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.